Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure

Authors
Publication date
1 January 2011
Publisher

Abstract

Purpose: To retrospectively evaluate the efficacy and tolerability of mitomycin-C (MMC) in combination with fluoropyrimidines as salvage 3rd -or 4th-line therapy in metastatic colorectal cancer (MCRC) patients

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Dokuz Eylul University Research Information System

    redirect
    oai06b1bc2d-79dd-4690-8985-a6b3d3...
    Last time updated on 20/03/2023